discovered that this triple therapy increased the number of CD8+ T cells and T memory cells around the tumor, promoted polarization of macrophages from an M2 to M1 phenotype, inhibited breast tumor growth, and prolonged the survival of mice. The gene discussed is CD8A; the disease is neoplasm.